Categories: HealthcareNews

Connecticut Proton Therapy Center selects RayCare

STOCKHOLM, Aug. 21, 2024 /PRNewswire/ — RaySearch Laboratories AB (publ) is pleased to announce that the Connecticut Proton Therapy Center, Wallingford, Connecticut, USA, has placed an order for the oncology information system RayCare®*.

The Connecticut Proton Therapy Center will be the first of its kind in the state of Connecticut and is a collaboration between Yale New Haven Health, Hartford HealthCare and Proton International. The center has selected RayCare and the IBA Proteus®ONE compact proton therapy system as its treatment platform.

RayCare will be Connecticut Proton Therapy Center’s only oncology information system and will be utilized with the ProteusONE proton system. The center will use the workflow engine of RayCare for creating clinic specific workflows, with the aim of a complete clinical implementation in 2026, when the center opens. RayCare will also be used together with RaySearch’s treatment planning system RayStation, which was acquired in 2023.

Johan Löf, founder and CEO, RaySearch, says: “We are happy to welcome yet another RayCare customer. For our installed base of RayStation customers the selection of RayCare as oncology information system will enhance efficiency and user experience, both in the treatment planning process and treatment delivery.”

Revenue from the order is expected to be recognized during 2025.

For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
johan.lof@raysearchlabs.com

* Subject to regulatory clearance in some markets.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/raysearch-laboratories/r/connecticut-proton-therapy-center-selects-raycare,c4026538

The following files are available for download:

View original content:https://www.prnewswire.com/news-releases/connecticut-proton-therapy-center-selects-raycare-302227390.html

SOURCE RaySearch Laboratories

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

41 minutes ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

4 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

4 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

4 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

4 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

4 hours ago